JOHN M. LEONARD - 03 Jan 2025 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
President and CEO, Director
Signature
James Basta, attorney-in-fact
Issuer symbol
NTLA
Transactions as of
03 Jan 2025
Transactions value $
-$326,509
Form type
4
Filing time
07 Jan 2025, 17:19:54 UTC
Previous filing
03 Jan 2025
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale -$327K -26.8K -2.77% $12.18 941K 03 Jan 2025 Direct F1
holding NTLA Common Stock 58.4K 03 Jan 2025 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.
F2 Shares held by the John M. Leonard 2015 Irrevocable Trust.